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ABSTRACT
Introduction: A significant proportion of patients with
primary Sjögren’s syndrome (PSS) is functionally
impaired and experience difficulties participating in
various aspects of everyday life. There is currently no
evidence of efficacy for non-pharmacological
interventions aimed specifically at supporting the
patients with PSS to improve their participation and
ability to perform daily activities. This paper describes
a research protocol for a mixed-methods study to
develop an intervention to improve these outcomes.
The protocol follows the Medical Research Council
framework for complex interventions.
Methods and analysis: We will use group concept
mapping with the patients, adults who live with them
and healthcare professionals to identify factors which
prevent people with PSS from participating in daily life
and performing daily activities. The factors will be
prioritised by participants for importance and feasibility
and will inform an intervention to be delivered within a
National Health Service (NHS) setting. Evidence-based
intervention techniques will be identified for the
prioritised factors and combined into a deliverable
intervention package. Key stakeholders will comment
on the intervention content and mode of delivery
through focus groups, and the data will be used to
refine the intervention. The acceptability and feasibility
of the refined intervention will be evaluated in a future
study.
Ethics and dissemination: The study has been
approved by an NHS Research Ethics Committee, REC
Reference: 13/NI/0190. The findings of this study will
be disseminated in peer-reviewed journals and through
presentation at national and international conferences.
Trial registration number: UKCRN Study ID: 15939.
BACKGROUND
Primary Sjögren’s syndrome (PSS) is an auto-
immune rheumatic condition which a recent
meta-analysis has identiﬁed as having a
prevalence rate of 74/100 000 inhabitants1
using the American European Consensus
Criteria (AECC).2 In addition to the classic
symptoms of oral and ocular dryness, arthral-
gia and myalgia3 the patients with PSS
experience signiﬁcant fatigue,4 sleep disturb-
ance,5 autonomic dysfunction6 and a mark-
edly reduced quality of life (QOL).7
Furthermore, PSS is associated with signiﬁ-
cant direct and indirect healthcare costs
equating to around £12–£15 000 per patient
per year.8 9
We recently conducted a literature review
on the impact of PSS on participation and
the ability to perform daily activities and con-
cluded that many patients with PSS are
restricted in their ability to participate in
various aspects of everyday life and are func-
tionally limited, which is affecting their
ability to carry out daily activities.10
Consistently, using the Improved HAQ, a vali-
dated instrument for assessing ability to
perform daily activities, we demonstrated
that people with PSS have signiﬁcant
Strengths and limitations of this study
▪ This study will allow people with primary
Sjögren’s syndrome, their families and healthcare
professionals to identify and prioritise key factors
or barriers to participation and daily activities.
▪ This information will allow us to develop an evi-
dence-based intervention to improve participation
and the ability to perform daily activities for
people with primary Sjögren’s syndrome.
▪ This study will result in an intervention package
and a feasibility study protocol in readiness for
testing the intervention for acceptability and feasi-
bility within a National Health Service setting.
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impairment that is comparable with those with chronic
fatigue syndrome.11
We also conducted a systematic review of non-
pharmacological interventions for PSS which identiﬁed
very few studies in the literature and concluded that there
was no current evidence for the effectiveness of non-
pharmacological interventions for PSS.12 Current medical
care for the patients with PSS has mainly focused on
pharmacological interventions for their classic symptoms,
which at best are only partially effective.13 Currently there
is no evidence of efﬁcacy for non-pharmacological inter-
ventions aimed at improving participation and the ability
to perform daily activities for the patients with PSS. This is
in contrast to patients with other long-term conditions
such as cancer, chronic fatigue syndrome and chronic
pain who have access to psychosocial therapies which have
been shown to improve symptoms and functional
ability.14–17 Therefore, there is a need to develop effective
interventions to improve function and participation in
everyday activities for people with PSS.
In order to develop an effective intervention that is
deliverable in the UK’s National Health Service (UK NHS),
it is important to understand what the key issues are for
service users, their families, healthcare professionals and
those who commission and manage NHS services for the
patients with PSS. This will maximise the likelihood that
the intervention addresses important issues and is feasible
and acceptable. The Medical Research Council (MRC)
framework for complex interventions18 advises an iterative
stepped, structured and mixed-methods approach. At the
early stages, when little is known regarding the determi-
nants of illness and illness-associated impairments, a com-
bination of qualitative techniques to explore patient
experience and a review of the existing evidence is recom-
mended. Such ﬁndings will then form the theoretical and
empirical basis for developing an intervention speciﬁc for
PSS. The key tasks are to identify intervention targets, the
mechanisms whereby the proposed intervention will lead
to change in participation and the ability to perform daily
activities. Furthermore, recommendations will be made for
speciﬁc measures to be used.
While the MRC guidance provides a useful framework
for intervention development, it is less clear on the
exact methods to achieve this. A variety of methods from
economic modelling to computer simulation have been
suggested, many of which may not be applicable to
complex psychosocial interventions. In this regard,
group concept mapping (GCM) methodology has been
used to good effect for strategic complex planning in
other diseases including dementia19 in addition to inter-
vention planning and treatment decisions in cancer.20 21
GCM, developed by Trochim,22 is a mixed-methods
participatory approach that uses a combination of group
processes (brainstorming, sorting, rating and group
interpretation) and a sequence of multivariate statistical
analysis (multidimensional scaling and hierarchical
cluster analysis) that result in visual representations of
all stakeholders opinions in the form of concept maps.
Priority values are added by participants to qualitative
statements gathered during the brainstorming phase
and these can be interpreted in pattern matches and
value plots and used in planning or evaluation studies.23
An advantage of GCM over some other methods is that
it is an equitable process, giving an equal voice to all
stakeholder groups and does not direct the participants
to form a consensus. In the rheumatology ﬁeld GCM
has been used to design interventions to prevent work
disability in patients with rheumatoid arthritis24 and to
understand their work requirements.25
In this study, we will identify priorities and intervention
strategies that could improve participation and the ability
to perform daily activities for people with PSS. The ﬁndings
of the GCM exercise will be used to identify priority factors
or targets, which are perceived to prevent the patients with
PSS from participating in daily activities. Furthermore, the
chosen factors will be measurable and tools selected to
measure change for each. Existing evidence for each iden-
tiﬁed factor will be identiﬁed from the literature as the
basis for the development of an intervention package
aimed at improving daily function for people with PSS.
The results of the concept maps and the planned develop-
ment package will be discussed in focus groups of the
patients with PSS, their family members or supporters and
generic occupational therapists working in the UK NHS.
The planned intervention will be further reﬁned, drawing
on feedback from those who will be at both the receiving
and delivery ends of the proposed intervention.
At the conclusion of this study a detailed feasibility
protocol will be drawn up following the proposed
CONSORT reporting guidelines for feasibility and pilot
studies26 and ethical approvals will be sought. The inter-
vention will subsequently be tested for feasibility on a
small number of the patients with PSS in an NHS setting
in a future study.
Although the project is primarily aimed to develop an
intervention for use in UK NHS settings, its ﬁndings
may be useful for other publicly funded health services
or private healthcare providers.
AIMS AND OBJECTIVES
Aim
To build a model for intervention in PSS.
Objectives
1. To collect data from different stakeholder groups for
priority intervention target areas in PSS.
2. To use existing clinical evidence to establish the
optimum intervention and mechanism of effect of
intervention for selected intervention targets.
3. To use existing clinical evidence to identify outcome
measures best suited to capturing intervention effect.
4. To establish which of these priority areas could be
realistically delivered within a UK NHS setting.
5. To design protocol for a future feasibility study of the
reﬁned intervention.
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METHODS AND ANALYSIS
We will use GCM to explore the perspectives of three
stakeholder groups on what will improve functional cap-
acity of the patients with PSS. The stakeholder groups
will be patients with PSS, adult household members
(here onwards referred to as ‘family’) who live with
someone who has PSS and healthcare professionals,
managers and commissioners (here onwards referred to
as ‘providers’) involved in the care delivery or service
provision for patients with PSS.
Sample size
The recommended minimum number of participants
for a GCM exercise is n=40.27 We will seek to recruit
approximately n=280 participants in order to enable
subgroup analyses and to allow for modest attrition rates
at each step of the GCM exercise (see ﬁgure 1). We aim
to recruit 50 providers, 50 family members and 180
patients with PSS. This will allow us to detect a differ-
ence of the same order of magnitude as the background
variability with 80% power. Subgroups within the patient
group will allow us to compare opinions of the patients
with PSS with varying levels of fatigue, QOL, perceived
dryness, pain, cognitive symptoms and mood
disturbances.
Recruitment
Patients who are participants in the UK Primary
Sjögren’s Syndrome Registry (UKPSSR)28 and have con-
sented to be approached about further studies will be
invited to take part in this study via a postal invitation.
Up to 12 patient identiﬁcation sites across England will
be used to identify potential participants. Family
members will be invited to participate in an invitation
addressed to an adult household member in the patient
invitation pack. Providers will be invited to participate at
professional meetings and through email invitation via
email distribution lists.
Consent
The participants will be sent an invitation pack in the
post. Within the pack will be a participant information
sheet, a consent form and a reply form. They will be
asked to reply to the invitation, indicating on the reply
form whether they would like to participate. They will be
provided with a telephone number and an email address
to contact the research team if they have any questions.
Once any queries have been satisﬁed they will be asked to
sign, complete and return the consent and reply forms.
Data collection
Baseline demographics will be collected from all the par-
ticipants (see ﬁgure 2). The PSS group will be asked to
complete self-assessment on mood, QOL, function,
fatigue, cognitive symptoms, dryness, discomfort and
pain using validated instruments (see ﬁgure 3). This will
allow us to perform subgroup analyses and compare
whether opinions differ or not within the patient group.
For example comparisons of the patients who are func-
tionally impaired with those who are not; or those who
are fatigued and those who are not. Family members will
be asked to complete short validated questionnaires to
Figure 1 Flow chart of the
participants to be recruited to the
PSS participant group (PSS,
primary Sjögren’s syndrome;
QOL, quality of life).
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measure the impact of their spouse/relative’s disease on
them as well as their own QOL, as this may inﬂuence
their opinion in the concept mapping exercise, regard-
ing what they feel as priority areas for a healthcare inter-
vention. Health care professionals (HCPs) will be asked
to indicate which professional group they belong to.
These data will allow us to perform additional subgroup
analyses within the family and provider groups.
BUILDING A MODEL FOR INTERVENTION IN PSS
GCM phase
Identifying factors: idea generation/brainstorming
We will seek open contribution of ideas from each stake-
holder group in response to a focus prompt. A focus
prompt is an incomplete sentence designed to elicit
ideas from the participants during the brainstorming
phase of a GCM exercise. To generate a range of factors,
the participants will be asked to complete the following
focus prompt:
People with primary Sjögren’s syndrome would be able to
do more of the things they want to do and the things
they have to do if…
The participants will be asked to think and record as
many responses as they can during this process.
Ideas analysis
All statements will be analysed and synchronised by a
study advisory group consisting of representatives of all
stakeholder groups and the research team. We will use a
structured process recommended by Kane and
Trochim23 to remove duplicate statements and ensure
Figure 2 Flow chart of concept mapping study (GP, general practitioner; UKPSSR, UK Primary Sjögren’s Syndrome Registry).
4 Hackett KL, et al. BMJ Open 2014;4:e006264. doi:10.1136/bmjopen-2014-006264
Open Access
 group.bmj.com on September 24, 2014 - Published by bmjopen.bmj.comDownloaded from 
wording is clear. This will condense the statement set to
one which is of manageable size (≤96 statements)27 for
the subsequent sorting and rating exercise but large
enough to ensure saturation of the topic.22 27
Structuring the factors: sorting and rating the statements
The participants who previously took part in the brain-
storming exercise will be invited to take part in the
sorting and rating phase. Some participants may be
recruited solely to the sorting and rating phase if satur-
ation of the brainstorming topic is achieved prior to
recruiting the planned number of participants, or if
there is signiﬁcant participant attrition between the two
phases of the study. The participants will be asked to
rate each statement in the distilled set on a ﬁve-point
rating scale for importance and feasibility. When asked
about feasibility they will be asked to consider how
realistic it is to address the particular issue presented by
the statement in an NHS setting. Next they will be asked
to sort the statements into themes or groups of similar
statements or ideas.
Procedures for the concept mapping phase
The patients with PSS and AHMs will be given the
option of participating in the concept mapping exercises
via one of the following means: (1) face-to-face focus
groups of 5–10 people (if they live within 10 miles of the
research centre), (2) a web-based interface or (3) paper-
based questionnaire. HCPs will participate via the online
web-based interface or on paper-based questionnaires.
The participants completing the web-based concept
mapping exercise will be given a unique username (not
their name) and password.
In the group brainstorming session, a trained facilita-
tor may use neutral prompts if ideas start to dry up. The
participants also have the option of completing their
responses on a piece of paper and handing it to a facili-
tator if they do not feel comfortable verbalising their
responses. In the online format, the participants will be
able to see the anonymous responses of the participants
who have already completed the brainstorming process,
which may help to prompt their own ideas. The partici-
pants choosing to complete the exercises on paper via
the post will have a blank piece of paper to record their
ideas on and will not have the beneﬁt of seeing other
peoples’ responses.
When conducting the sorting and rating exercises, the
participants may choose a different method to their
chosen one for brainstorming if they wish. For example,
they may complete the sorting and rating exercise
online if they attended a face-to-face meeting for brain-
storming. Furthermore, the participants may take part in
sorting or rating even if they did not originally under-
take the brainstorming exercise.
Concept mapping analysis and interpretation
The data generated from the above exercises will be ana-
lysed and represented in objective form as visual maps
using the Concept Systems Global software package.
The maps will highlight the priority areas for each
stakeholder group in improving function of the patients
with PSS. Similarities and disparities between the stake-
holder groups can be identiﬁed and if appropriate sub-
group analyses will be carried out using the baseline
demographic data collected at the start of the study and
the self-assessment data. The “go zones” represent areas
that are of most importance for more than one stake-
holder group and so are of particular importance for
planning interventions.
Intervention development phase
The key barriers or factors identiﬁed in the GCM exer-
cises will be used as the basis for developing interven-
tions and selecting appropriate measures which can be
used later for a formal evaluation of effectiveness. We
Figure 3 Measures to be used during the concept mapping
phase (AHM, adult household member; HADS, Hospital
Anxiety and Depression Scale; PSS, primary Sjögren’s
syndrome). **The activity interference grid from the CPEQ.
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will use an existing, reportable method described by
Kolehmainen and Francis29 to identify the techniques to
be used in the intervention and will review existing lit-
erature to identify the measures. This involves three
steps.
First, potential intervention techniques (active ingredi-
ents) will be identiﬁed from existing literature and rele-
vant evidence-based theories. These will be identiﬁed in
relation to the prioritised factors. Where the literature to
indicate a technique for a factor is scarce, evidence-based
theories from related ﬁelds, such as behaviour change
will be used. Existing tools such as a matrix of behaviour
change techniques30 enable systematic identiﬁcation of
techniques from these ﬁelds. Second, the factor is speci-
ﬁed as an observable and measurable ‘construct’ and a
measure for identifying change in it will be selected.
Third, each technique and factor pair is presented as a
testable hypothesis in relation to the primary outcome.
An illustrative example of the application of this three-
step method is shown below.
Illustrative example: potential factor—chronic fatigue
Evidence-based intervention techniques to target
chronic fatigue include, grading physical activity/exer-
cise15 and goal setting, biofeedback and body changes.30
Chronic fatigue is commonly measured as the self-
reported mental and physical tiredness, by using tools
such as the Chalder Fatigue Scale31 or the Proﬁle of
Fatigue.32 The testable hypothesis may be articulated as
“grading, goal setting, biofeedback and body changes
can be used to reduce chronic fatigue in order to
increase participation in meaningful occupations.”
The intervention will be reported using the Template
for Intervention Description and Replication
(TIDieR).33
Intervention refinement phase: focus groups
Once the potential intervention techniques have been
identiﬁed from the literature, these will be presented to
people with PSS, their families and occupational thera-
pists in focus groups. The focus groups will provide
opportunities to gather feedback regarding the speciﬁc
intervention techniques, how the techniques will be best
delivered and measures of effectiveness. The participants
will be asked to generate ideas regarding how to deliver
the techniques in an effective and acceptable way.
Patient and carer participants will be identiﬁed from a
regional specialist medical service for PSS and will be
those who have previously indicated an interest at being
involved with further research. Potential therapist parti-
cipants will be recruited from local hospitals and
community-based occupational therapists.
In addition the focus group participants will be invited
to comment on the proposed outcome measures,
including the choice of instrument(s) and the processes
of administering and completing these instrument(s).
The results will be used to reﬁne the intervention
package.
Designing a feasibility study
Once the intervention has been designed and the meas-
urement tools identiﬁed, a detailed protocol following
CONSORT guidance26 will be drawn up and ethical
approvals sought. This will form the next stage of the
intervention development process.
ETHICS AND DISSEMINATION PLAN
This study has received approvals from the Ofﬁce for
Research Ethics Committees Northern Ireland (Ref:
13/NI/0190) and has been adopted onto the UK
Clinical Research Network Study Portfolio (UKCRN
Study ID: 15939). The results from both the concept
mapping phase and an outline of the reﬁned interven-
tion will be disseminated nationally and internationally
and submitted to scientiﬁc journals for publication.
SUMMARY
This study seeks to identify important factors from the
patients with PSS, their families and providers regarding
what could improve participation and the ability to
perform daily activities for people with PSS. The identi-
ﬁed factors will be targets for speciﬁc evidence-based
intervention techniques and appropriate measures will
be identiﬁed for each. This will result in an intervention
package which will be reﬁned in focus group discussions
with key stakeholders. The next stage of the intervention
development process will be a feasibility study of the
reﬁned intervention and this will be the subject of a
future protocol.
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